News Headlines Article

Let Medicare negotiate drug prices: Our view
USA Today

Recent disclosures of how much Medicare pays doctors provoked news stories about patients getting hyperexpensive drugs for cancer, glaucoma and other diseases — and providers getting rich in the process.

Medicare’s “Part B” program pays roughly $20 billion a year for the drugs patients get in doctors’ offices and hospital outpatient facilities.